Bayer and German-based life science company, Evotec, have updated the focus of their strategic collaboration to developing innovative precision treatments for cardiovascular diseases (CVDs).
The...
The U.S. Food and Drug Administration has approved Neurocrine Biosciences' INGREZZA SPRINKLE (valbenazine) capsules, a new oral granules formulation of INGREZZA (valbenazine) capsules prescribed...
Novartis has entered into an agreement to acquire Mariana Oncology, a preclinical-stage biotechnology company based in Watertown, Massachusetts focused on developing novel radioligand therapies...